Should HFrEF patients with NYHA class II expect benefit from CCM therapy? Results from the MAINTAINED observational study. - Fastner C; Yuecel G; Hetjens S; Rudic B; Schmiel G; Toepel M; Liebe V; Kruska M; Borggrefe M; Burkhoff D; Akin I; Duerschmied D; et al. (Clinical research in cardiology : official journal of the German Cardiac Society, 2022)